Holen Sie sich die Stockscreener-App
149.45
1.61%
-2.44
Handel nachbörslich:
149.45
Charles River Laboratories International Inc Aktie (CRL) Neueste Nachrichten
Medical Device Testing Market Trends | Regulatory Compliance - openPR.com
Charles River Laboratories credit outlook lowered to stable at S&P on weak 2025 guidance - MSN
Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2024 Earnings Call Transcript - MSN
Charles River surges after Q1 beat, guidance raise - MSN
Insiders At Charles River Laboratories International Sold US$2.8m In Stock, Alluding To Potential Weakness - simplywall.st
Rhumbline Advisers Increases Stake in Charles River Laboratories International, Inc. (NYSE:CRL) - MarketBeat
Transcript : Charles River Laboratories International, Inc. Presents at 45th Annual William Blair Growth Stock Conference, Jun-03-2025 10 - marketscreener.com
Polen U.S SMID Company Growth Strategy Sold Charles River Laboratories International (CRL) for More Attractive Opportunities - Insider Monkey
Charles River Laboratories International Inc. stock outperforms competitors on strong trading day - MSN
Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report? - Yahoo Finance
Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - GlobeNewswire Inc.
William Blair Remains a Hold on Charles River Labs (CRL) - The Globe and Mail
Charles River at Jefferies Conference: Strategic Moves Amid Challenges By Investing.com - Investing.com Canada
Transcript : Charles River Laboratories International, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 10 - marketscreener.com
Charles River Laboratories To Present At Jefferies Global Conference; Webcast At 10:30 AM ET - Nasdaq
Cell Banking Outsourcing Market To Witness Substantial Growth, - openPR.com
Charles River Stock May Gain From Extended CHDI Research Deal on HD - MSN
Charles River Laboratories International Inc (CRL) Shares Up 3.0 - GuruFocus
Charles River at William Blair Conference: Navigating Challenges with Innovation - Investing.com Australia
Charles River Laboratories To Present At William Blair Growth Stock Conference; Webcast At 11:00 AM - Nasdaq
Charles River Laboratories to Present at William Blair and Jefferies Conferences - BioSpace
Charles River Laboratories to Present at William Blair and Jeffe - GuruFocus
Charles River Laboratories to Present at William Blair and Jefferies Conferences | CRL Stock News - GuruFocus
Charles River Laboratories International, Inc. (CRL): A Bull Case Theory - Insider Monkey
Do Wall Street Analysts Like Charles River Laboratories Stock? - MSN
Charles River Laboratories, CHDI Foundation Extend Collaboration - marketscreener.com
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - BioSpace
Charles River Laboratories International Extend Drug Discovery Partnership With CHDI Foundation - marketscreener.com
Charles River Labs extends Huntington’s disease research pact By Investing.com - Investing.com India
Charles River (CRL) and CHDI Foundation Extend Partnership for H - GuruFocus
Charles River Labs extends Huntington’s disease research pact - Investing.com Australia
Charles River (CRL) and CHDI Foundation Extend Partnership for Huntington's Drug Discovery | CRL Stock News - GuruFocus
Charles River Laboratories (CRL) and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research - StreetInsider
Redburn Upgrades Charles River Laboratories (CRL) to Buy, Cuts PT - MSN
Should You Continue to Hold Charles River Stock in Your Portfolio? - MSN
There's No Escaping Charles River Laboratories International, Inc.'s (NYSE:CRL) Muted Revenues Despite A 25% Share Price Rise - simplywall.st
Charles River Laboratories International, Inc. (CRL) Extends CEO's Employment Agreement - GuruFocus
Charles River (CRL) Upgraded to Buy Amid Strategic Developments | CRL Stock News - GuruFocus
Redburn raises Charles River Labs to buy, cuts price target to $182 - Investing.com Nigeria
Redburn raises Charles River Labs to buy, cuts price target to $182 By Investing.com - Investing.com South Africa
Charles River Laboratories International CEO James C. Foster's Employment Extended Until February 2027SEC Filing - marketscreener.com
Charles River Labs Extends CEO’s Term Amid Shareholder Meeting - TipRanks
This Waste Management Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday - Benzinga
CRL Stock Upgraded to 'Buy' by Redburn Atlantic Despite PT Reduc - GuruFocus
CRL Stock Upgraded to 'Buy' by Redburn Atlantic Despite PT Reduction | CRL Stock News - GuruFocus
Charles River (CRL) Seen as Beneficiary of Potential Earnings Gr - GuruFocus
Charles River (CRL) Seen as Beneficiary of Potential Earnings Growth | CRL Stock News - GuruFocus
Redburn Atlantic Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $182 From $188 - marketscreener.com
0.65%
2.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):